Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 9,815.0 | 8,766.5 | 8,450.0 | 8,472.7 | 7,752.0 | 7,639.1 | 7,954.8 | 7,741.9 |
| Revenue growth | 12.0% | 3.7% | -0.3% | 9.3% | 1.5% | -4.0% | 2.8% | 6.0% |
| Cost of goods sold | 1,739.7 | 1,480.3 | 1,363.1 | 1,335.2 | 1,307.1 | 1,342.1 | 1,329.3 | 1,427.6 |
| Gross profit | 8,075.3 | 7,286.2 | 7,086.9 | 7,137.5 | 6,444.9 | 6,297.0 | 6,625.5 | 6,314.3 |
| Gross margin | 82.3% | 83.1% | 83.9% | 84.2% | 83.1% | 82.4% | 83.3% | 81.6% |
| Selling, general and administrative | | | | | | | | |
| General and administrative | 830.0 | 752.8 | 711.0 | 729.8 | 676.8 | 634.1 | 590.6 | 561.4 |
| EBITA | 2,225.3 | 2,166.4 | 2,025.5 | 1,952.0 | 1,978.2 | 1,841.3 | 1,764.2 | 1,632.8 |
| EBITA margin | 22.7% | 24.7% | 24.0% | 23.0% | 25.5% | 24.1% | 22.2% | 21.1% |
| Amortization of intangibles | 232.0 | 177.7 | 195.4 | 252.0 | 90.0 | | | |
| EBIT | 1,993.3 | 1,988.7 | 1,830.1 | 1,699.9 | 1,888.2 | 1,841.3 | 1,764.2 | 1,632.8 |
| EBIT margin | 20.3% | 22.7% | 21.7% | 20.1% | 24.4% | 24.1% | 22.2% | 21.1% |
| Pre-tax income | 1,572.3 | 1,558.9 | 1,190.1 | 1,329.5 | 1,574.4 | 1,504.8 | 1,426.0 | 1,295.4 |
| Income taxes | 344.2 | 346.2 | 273.5 | 289.0 | 578.9 | 555.0 | 540.0 | 468.3 |
| Tax rate | 21.9% | 22.2% | 23.0% | 21.7% | 36.8% | 36.9% | 37.9% | 36.2% |
| Earnings from continuing ops | -7.5 | -7.5 | -7.5 | -7.5 | -7.5 | -7.5 | -7.5 | 819.5 |
| Earnings from discontinued ops | 1,228.0 | 1,212.7 | 916.6 | 1,040.5 | 995.5 | 949.8 | 886.0 | |
| Net income | 1,220.5 | 1,205.2 | 909.1 | 1,033.0 | 988.0 | 942.3 | 878.5 | 819.5 |
| Net margin | 12.4% | 13.7% | 10.8% | 12.2% | 12.7% | 12.3% | 11.0% | 10.6% |
| |
| Diluted EPS | ($0.02) | ($0.02) | ($0.02) | ($0.02) | ($0.02) | ($0.02) | ($0.02) | $2.58 |
| Shares outstanding (diluted) | 344.6 | 339.8 | 322.9 | 318.0 | 318.0 | 318.5 | 318.4 | 317.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|